Meta-variability of advice on drugs in the breastfeeding mother: The example of β-blockers

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 93, Issue 3, 2008, Pages

  Davanzo, R ^a   Rubert, L ^a   Oretti, C ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; NADOLOL; PROPRANOLOL; PSYCHOTROPIC AGENT;

BREAST FEEDING; BREAST MILK; CLINICAL PRACTICE; DRUG SAFETY; DRUG UTILIZATION; HUMAN; LETTER; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL LITERATURE; MOTHER; PRIORITY JOURNAL; REFERENCE DATABASE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ATTITUDE TO HEALTH; DRUG CONTRAINDICATION; FEMALE; HEALTH PERSONNEL ATTITUDE; PRACTICE GUIDELINE; RISK MANAGEMENT;

ADRENERGIC BETA-ANTAGONISTS; ATTITUDE OF HEALTH PERSONNEL; BREAST FEEDING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK MANAGEMENT;

EID: 44049108180     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2007.135764     Document Type: Letter

References (5)

1. American Academy of Pediatrics, Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-89.
2. World Heath Organization. Department of Child and Adolescent Health and Development. Breastfeeding and maternal medication. Recommendations of drugs in the eleventh WHO model list for essential drugs. Geneva: WHO, 2002.
3. Briggs GG, Freeman RK, Sumner JY. Drugs in pregnancy and lactation, 7th edn. Philadelphia: Lippincott, Williams and Wilkins, 2005.
4. Hale TW. Medications and mother's milk, 13th edn. Amarillo, TX: Pharmasoft Publishing, 2006.
5. TOXNET, Toxicology Data Network. LactMed. http://www.pubmed.gov (accessed June 2007).